Prevención e Intervención en Suicidio (SURVIVE): estudio de cohorte y ensayos clínicos-controlados anidados de programas de prevención secundaria para intentos de suicidio

Resumen del proyecto

BACKGROUND: Suicide is the leading cause of avoidable death worldwide. Gathering national data regarding the incidence of suicidal behavior and effective secondary prevention strategies is mandatory to develop evidence-based public-policies. OBJECTIVES: 1) to determine the incidence of suicide attempts in Spain, 2) to follow up suicide attempters with the aim of studying the probability of them re-attempting, 3) to identify influential risk factors to explain suicide attempts and an increased risk of re-attempting, 4) to determine the efficacy of secondary prevention programs to prevent suicide re-attempts in comparison to treatment as usual (TAU), and 5) to create a national platform for suicide study and prevention. METHODS: Multi-site-coordinated cohort study with three nested randomized controlled trials. Participants will be recruited at nine sites distributed across Spain. The primary outcome will be subsequent suicide attempts (and/or suicide mortality) captured across assessment waves. SUB-PROJECT 1: prospective cohort study of individuals presenting a suicide attempt (n = 2000). Individuals would be followed for 1-year, and assessed every 3 months. SUB-PROJECT 2: will test the efficacy of secondary prevention programs to prevent suicide. Individuals over 18 years will be randomly allocated to the following interventions: a) telephone-management or, b) online self-management tool (iFD), these interventions will be tested against TAU. Individuals between 12 and 18 years will be randomized to a tailored program to prevent suicide in adolescents (YAM) or TAU. SUB-PROJECT 3 will entail the development of a national platform for the study and prevention of suicide.

Palabras clave

suicidio
intento de suicidio
cohorte
factores de riesgo
prevención secundaria
salud mental

Convocatoria

Acción Estratégica en Salud (AES)

Periodo de ejecución

01/01/2020 - 31/12/2022

Investigador Principal

DIAZ MARSA, MARINA

Centro beneficiario

FUNDACION INVESTIGACION BIOMEDICA HOSPITAL CLINICO SAN CARLOS

Centro de realización

INSTITUTO DE INVESTIGACION SANITARIA DEL HOSPITAL CLINICO SAN CARLOS (IdISSC)

Comunidad Autónoma

MADRID

Provincia

MADRID

Financiación

52,030 €